eToro Partner Tweets (Powered By Twitter)

RT Sam North: Really enjoyed sitting down with daRealAAkinfenwa to discuss the 'The Reality of Football Money Outside the Premier Leagu…

Moderna and Merck’s melanoma vaccine success is a major confidence boost for investors, particularly for Moderna, which has been searching for its next growth engine after the Covid boom faded. A successful Phase 3 cancer trial gives investors stronger evidence that mRNA technology can have a meaningful future beyond infectious diseases. For Merck, the result could help strengthen its oncology business as it prepares for the eventual loss of patent protection on Keytruda. A personalized vaccine used alongside Keytruda could support future growth and increase the value of its cancer franchise. The sharp share-price reaction reflects that potential, but we think that retail investors should keep expectations measured. The companies have not yet released the full trial data, overall survival results are still pending, and manufacturing personalized vaccines at scale could be expensive and complex. Investors should therefore watch for next important steps which will be detailed clinical results, regulatory progress and evidence that the technology works across other cancers.

Agentic trading. Tokenized equities. Bitcoin as digital gold. Our co-founder and CEO Yoni Assia joined Anthony Pompliano 🌪 to unpack where markets are headed and how AI is reshaping the way investors decide, not just what they decide. Full conversation 👇 youtube.com/watch?app=desk…

What's your Edge setup? https://t.co/LesdfxQctv

Successful drivers and investors have one thing in common: experience matters 💪 PIERRE GASLY 🇫🇷 https://t.co/sSoMgTWp4R

Meet etoro edge. The intelligent terminal. Built around you. Scroll to discover more. 👉

A spotlight on the etoro Q2 etoro earning results from our CFO, Meron Shani.   We delivered: - Net contribution up 9% year-over-year to $229 million. - Adjusted EBITDA up 9% to $78 million. - Funded accounts up 18% to 4.28 million. - Assets under administration up 10% to $19.2 billion.

Real-time conversations have become a market signal. We spoke with Federico Paderni, Managing Director, EMEA Growth at X, about the eToro🤝X partnership, how Tori (powered by Grok) brings real-time sentiment straight to investors, and the role AI will play in breaking down barriers to information.

Update from NYC 🗽
 Q2 delivered +9% growth in Net Contribution & Adjusted EBITDA and +18% growth in Funded Accounts. More markets. More AI. 
 From 24/7 AI trading, to Zengo unlocking new crypto & DeFi markets, to TradeZero expanding US opportunities, the future of investing is here.

RT Yoni Assia: I had to stop by the @TradeZero booth at NYSE 🏛 Went live on CNBC while I was there to talk Q2 results. Full interview:…

RT Yoni Assia: I had to stop by the @TradeZero booth at NYSE 🏛 Went live on CNBC while I was there to talk Q2 results. Full interview:…

We are officially live in the @Grok connector catalog! 🎉 Search "etoro" in Grok's connectors, connect the official listing, and sign in. No custom URL, no API keys needed. Full setup walkthrough below. Built with @etorobuilders.

etoro Q2 2026 results are out. Swipe through to explore the Q2 highlights.

etoro Q2 Results Are Live! Check out the latest shareholder update on our Investor Relations website 👉 investors.etoro.com At 08:30 AM ET / 1:30 PM UK, our CEO and CFO will also break down the results LIVE on X.

Volume up 🔊 etoro edge edge baby. Check out etoro edge https://t.co/oXTPFdAV59